Douglas Lane & Associates’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$210K Sell
1,898
-581
-23% -$64.4K ﹤0.01% 232
2025
Q1
$278K Buy
+2,479
New +$278K ﹤0.01% 211
2024
Q1
Sell
-2,731
Closed -$221K 248
2023
Q4
$221K Sell
2,731
-20
-0.7% -$1.62K ﹤0.01% 226
2023
Q3
$206K Sell
2,751
-665
-19% -$49.8K ﹤0.01% 225
2023
Q2
$263K Sell
3,416
-305
-8% -$23.5K ﹤0.01% 205
2023
Q1
$309K Buy
3,721
+413
+12% +$34.3K 0.01% 201
2022
Q4
$284K Buy
+3,308
New +$284K ﹤0.01% 203
2022
Q1
Sell
-4,056
Closed -$295K 227
2021
Q4
$295K Sell
4,056
-30
-0.7% -$2.18K ﹤0.01% 204
2021
Q3
$285K Buy
4,086
+141
+4% +$9.84K ﹤0.01% 199
2021
Q2
$272K Buy
3,945
+134
+4% +$9.24K ﹤0.01% 199
2021
Q1
$246K Sell
3,811
-713
-16% -$46K ﹤0.01% 196
2020
Q4
$264K Buy
4,524
+207
+5% +$12.1K ﹤0.01% 192
2020
Q3
$273K Sell
4,317
-350
-7% -$22.1K 0.01% 184
2020
Q2
$359K Buy
4,667
+463
+11% +$35.6K 0.01% 171
2020
Q1
$314K Buy
4,204
+11
+0.3% +$822 0.01% 173
2019
Q4
$272K Sell
4,193
-412
-9% -$26.7K 0.01% 190
2019
Q3
$292K Sell
4,605
-655
-12% -$41.5K 0.01% 187
2019
Q2
$355K Sell
5,260
-5,708
-52% -$385K 0.01% 186
2019
Q1
$713K Buy
10,968
+48
+0.4% +$3.12K 0.01% 160
2018
Q4
$683K Sell
10,920
-1,808
-14% -$113K 0.02% 157
2018
Q3
$983K Buy
12,728
+651
+5% +$50.3K 0.02% 147
2018
Q2
$856K Sell
12,077
-250
-2% -$17.7K 0.02% 150
2018
Q1
$929K Buy
12,327
+150
+1% +$11.3K 0.02% 141
2017
Q4
$872K Buy
12,177
+452
+4% +$32.4K 0.02% 148
2017
Q3
$950K Buy
11,725
+1,715
+17% +$139K 0.02% 148
2017
Q2
$709K Sell
10,010
-388
-4% -$27.5K 0.02% 156
2017
Q1
$706K Buy
10,398
+235
+2% +$16K 0.02% 161
2016
Q4
$728K Sell
10,163
-1,189
-10% -$85.2K 0.02% 162
2016
Q3
$898K Sell
11,352
-607
-5% -$48K 0.02% 158
2016
Q2
$998K Sell
11,959
-1,106
-8% -$92.3K 0.03% 154
2016
Q1
$1.2M Buy
+13,065
New +$1.2M 0.03% 150